Cargando…
A Re-evaluation of the “Oncogenic” Nature of Wnt/β-catenin Signaling in Melanoma and Other Cancers
In cancer, Wnt/β-catenin signaling is ubiquitously referred to as an “oncogenic” pathway that promotes tumor progression. This review examines how the regulation and downstream effects of Wnt/β-catenin signaling in cancer varies depending on cellular context, with a focus on malignant melanoma. We e...
Autores principales: | Lucero, Olivia M., Dawson, David W., Moon, Randall T., Chien, Andy J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910886/ https://www.ncbi.nlm.nih.gov/pubmed/20603725 http://dx.doi.org/10.1007/s11912-010-0114-3 |
Ejemplares similares
-
Activation of Wnt/β-Catenin Signaling Increases Apoptosis in Melanoma Cells Treated with Trail
por: Zimmerman, Zachary F., et al.
Publicado: (2013) -
WNT/β-catenin signaling regulates mitochondrial activity to alter the oncogenic potential of melanoma in a PTEN-dependent manner
por: Brown, K, et al.
Publicado: (2017) -
Targeted BRAF Inhibition Impacts Survival in Melanoma Patients with High Levels of Wnt/β-Catenin Signaling
por: Chien, Andy J., et al.
Publicado: (2014) -
FAM129B is a novel regulator of Wnt/β-catenin signal transduction in melanoma cells
por: Conrad, Willliam, et al.
Publicado: (2013) -
Protein Kinase PKN1 Represses Wnt/β-Catenin Signaling in Human Melanoma Cells
por: James, Richard G., et al.
Publicado: (2013)